XORTX Therapeutics (XRTX) Interest Expenses (2020 - 2023)

XORTX Therapeutics' Interest Expenses history runs 4 years deep, the most recent figure standing at $1379.0 for Q1 2023.

• Quarterly Interest Expenses fell 47.92% year-over-year to $1379.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $1379.0 (down 98.67% YoY) and the FY2025 annual result came in at $41870.0, down 65.65% from the prior year.
• Interest Expenses was $1379.0 for Q1 2023 at XORTX Therapeutics, down from $53723.3 in the prior quarter.
• Across five years, Interest Expenses topped out at $53723.3 in Q4 2022 and bottomed at -$1487.0 in Q1 2021.
• A 4-year average of $9028.1 and a median of -$541.0 in 2021 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2021 — Interest Expenses slumped 111.8% — and 2022, when it jumped 4157.41%.
• XORTX Therapeutics' Interest Expenses stood at -$625.15 in 2020, then slumped by 111.8% to -$1324.1 in 2021, then soared by 4157.41% to $53723.3 in 2022, then plunged by 97.43% to $1379.0 in 2023.
• Business Quant data shows XRTX's Interest Expenses at $1379.0 in Q1 2023, $53723.3 in Q4 2022, and $35485.0 in Q3 2022.